SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Interim Management Statement

9 May 2013 07:00

RNS Number : 2866E
Tullett Prebon PLC
09 May 2013
 

9 May 2013

 

Tullett Prebon plc

 

AGM Statement and Interim Management Statement

 

Tullett Prebon plc (the "Company") is today issuing its Interim Management Statement in relation to the period from 1 January 2013. This statement will be delivered to those attending the Annual General Meeting today.

 

Business Update

 

As expected, market conditions have continued to be challenging. The level of activity in the world's financial markets has remained subdued reflecting persistently low volatility. Market volumes also continue to be adversely affected by the more onerous regulatory environment applicable to many of our customers, and by the considerable uncertainty over the impact of new regulations covering the OTC markets, both of which reduce our customers' ability and willingness to trade.

 

Revenue in the four months to April was £293m, 4% lower than reported for the equivalent period last year. At constant exchange rates revenue was also 4% lower.

 

The business has continued to develop its hybrid electronic broking offering to comply with regulatory requirements and to respond to market demand. We are well prepared for the implementation in the USA of the rules relating to swap and security-based swap execution facilities, and we intend to launch platforms in the USA for those products which are within the scope of the rules after those rules have been published in final form.

 

We have recently finalised the terms of a participation agreement under which a minimum of 12 leading banks will supply electronic streaming liquidity for Euro interest rate derivatives through tpSWAPDEAL, our interest rate swap platform.

 

Legal action continues to be pursued against BGC and former employees in the USA in response to the raid on the business by BGC in the second half of 2009. The FINRA arbitration on the claim brought by the subsidiary companies in the United States directly affected by the raid is expected to continue through the first half of this year. The outcome of the arbitration is expected to be determined before the end of the year. A separate action is being pursued by the Company and the directly affected subsidiaries in the New Jersey Superior Court, alleging, among other causes of action, violations under the NJ RICO Act. Discovery is ongoing and no trial date has been set. Since 1 January, £6.8m of costs have been incurred in relation to these actions. Consistent with the treatment adopted in 2012, these costs will be recognised as an exceptional charge in the 2013 accounts.

 

On 19 April the Company entered into a new three year £150m revolving credit facility replacing the previous bank facilities. All the outstanding bank term debt under the previous facility has now been repaid. The Company's financial position remains strong.

 

 

 

Enquiries:

 

Nigel Szembel, Head of Communications, Tullett Prebon plc

Direct: +44 (0)20 7200 7722

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLGDUIGGBGXI
Date   Source Headline
26th Mar 20181:26 pmRNSAllotment of consideration shares
26th Mar 201811:01 amRNSDirector/PDMR Shareholding
14th Mar 20185:19 pmRNSDirector/PDMR Shareholding
13th Mar 20187:00 amRNSFinal Results
8th Jan 20187:00 amRNSAcquisition
5th Jan 20181:24 pmRNSTotal Voting Rights
5th Jan 20187:00 amRNSNotice of Results
15th Dec 20177:00 amRNSDirector/PDMR Shareholding
8th Dec 201712:52 pmRNSHolding(s) in Company
8th Dec 20177:00 amRNSDirectorate Change
30th Nov 20177:00 amRNSAcquisition of Coex Partners Limited
30th Nov 20177:00 amRNSCapital Markets Update
29th Nov 20173:45 pmRNSDirector/PDMR Shareholding
23rd Nov 20174:26 pmRNSHolding(s) in Company
22nd Nov 201711:54 amRNSHolding(s) in Company
3rd Nov 20177:00 amRNS3rd Quarter Trading Update
17th Oct 20177:00 amRNSDirectorate Change
5th Oct 20179:58 amRNSHolding(s) in Company
29th Sep 20178:21 amRNSHolding(s) in Company
22nd Sep 20173:58 pmRNSHolding(s) in Company
22nd Sep 201712:28 pmRNSHolding(s) in Company
30th Aug 20173:33 pmRNSHolding(s) in Company
8th Aug 20177:00 amRNSFinancial and Interim Management Report
17th Jul 201710:33 amRNSHolding(s) in Company
14th Jul 201712:38 pmRNSHolding(s) in Company
22nd Jun 20179:53 amRNSHolding(s) in Company
16th Jun 201711:37 amRNSHolding(s) in Company
22nd May 20173:02 pmRNSDirector/PDMR Shareholding
15th May 20172:52 pmRNSDirector/PDMR Shareholding
11th May 20174:45 pmRNSResult of Annual General Meeting
11th May 20177:02 amRNSBalance Sheet Strengthens with £270m Bulk Annuity
11th May 20177:00 amRNSAGM Statement and Trading Update
6th Apr 201711:00 amRNSAnnual Financial Report
5th Apr 201711:57 amRNSDirector/PDMR Shareholding
27th Mar 20174:41 pmRNSDirector/PDMR Shareholding
14th Mar 20177:00 amRNSFinal Results
28th Feb 201712:27 pmRNSNotice of Results
21st Feb 20179:29 amRNSHolding(s) in Company
24th Jan 20176:04 pmRNSTP ICAP GBP 7yr - Post-Stabilisation Notice
24th Jan 20174:42 pmRNSPublication of Final Terms
19th Jan 20175:29 pmRNSIssue of £500m Fixed Rate Senior Unsecured Notes
19th Jan 20178:39 amRNSTP ICAP GBP 7yr - Pre-Stabilisation Notice
18th Jan 201711:03 amRNSPublication of a Prospectus
16th Jan 20176:06 pmRNSHolding(s) in Company
12th Jan 20174:47 pmRNSHolding(s) in Company
12th Jan 20174:42 pmRNSHolding(s) in Company
12th Jan 20174:28 pmRNSHolding(s) in Company
10th Jan 201710:12 amRNSHolding(s) in Company
6th Jan 201710:54 amRNSPublication of a Prospectus
6th Jan 20177:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.